| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
20,825 |
19,265 |
$7.23M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,824 |
13,826 |
$3.36M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,678 |
8,252 |
$1.56M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
16,327 |
14,562 |
$1.05M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,876 |
8,079 |
$1.01M |
| 36415 |
Collection of venous blood by venipuncture |
23,617 |
20,728 |
$424K |
| H2035 |
Alcohol and/or other drug treatment program, per hour |
3,409 |
560 |
$403K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,873 |
1,467 |
$398K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,590 |
4,017 |
$393K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,643 |
2,229 |
$270K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,839 |
1,497 |
$250K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,761 |
1,724 |
$234K |
| 80053 |
Comprehensive metabolic panel |
15,113 |
13,017 |
$212K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,950 |
7,087 |
$131K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,826 |
2,435 |
$112K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,321 |
6,471 |
$90K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
311 |
292 |
$73K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
419 |
381 |
$69K |
| 71046 |
Radiologic examination, chest; 2 views |
2,043 |
1,855 |
$65K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
792 |
749 |
$49K |
| 93798 |
|
581 |
90 |
$49K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
373 |
360 |
$44K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
238 |
160 |
$44K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
12,375 |
8,937 |
$37K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,194 |
2,091 |
$34K |
| G0378 |
Hospital observation service, per hour |
207 |
134 |
$32K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
545 |
427 |
$25K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
234 |
148 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,705 |
16,962 |
$21K |
| 76820 |
|
321 |
200 |
$18K |
| A9270 |
Non-covered item or service |
1,923 |
1,057 |
$15K |
| 76801 |
|
130 |
118 |
$15K |
| 59025 |
Fetal non-stress test |
86 |
56 |
$14K |
| 90837 |
Psychotherapy, 53 minutes with patient |
283 |
161 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
214 |
183 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
638 |
612 |
$10K |
| 11043 |
|
16 |
12 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
213 |
197 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
105 |
101 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
180 |
173 |
$8K |
| 85027 |
|
10,399 |
9,277 |
$7K |
| 84484 |
|
3,607 |
2,673 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,138 |
6,083 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
38 |
25 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
59 |
55 |
$5K |
| 90832 |
Psychotherapy, 30 minutes with patient |
52 |
30 |
$5K |
| 81001 |
|
6,437 |
5,948 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
12 |
$4K |
| 70450 |
Computed tomography, head or brain; without contrast material |
87 |
78 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
40 |
26 |
$4K |
| 97597 |
|
123 |
83 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,075 |
3,565 |
$3K |
| J3490 |
Unclassified drugs |
1,404 |
1,091 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,090 |
986 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
290 |
224 |
$2K |
| 83690 |
|
3,350 |
3,046 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
106 |
105 |
$2K |
| 82962 |
|
392 |
122 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
31 |
31 |
$2K |
| 83735 |
|
2,143 |
1,937 |
$2K |
| 82248 |
|
3,099 |
2,849 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
13 |
$2K |
| 73630 |
|
14 |
12 |
$1K |
| 20552 |
|
13 |
13 |
$978.33 |
| 83880 |
|
15 |
12 |
$686.71 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
309 |
186 |
$435.70 |
| 85610 |
|
338 |
273 |
$429.50 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
769 |
694 |
$426.52 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,526 |
1,236 |
$395.80 |
| 96040 |
|
14 |
13 |
$315.15 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
13 |
$289.66 |
| 81003 |
|
370 |
339 |
$267.90 |
| 81025 |
|
671 |
614 |
$267.81 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,457 |
1,337 |
$189.47 |
| 82607 |
|
14 |
12 |
$181.51 |
| 87650 |
|
403 |
381 |
$177.40 |
| 85379 |
|
48 |
40 |
$164.87 |
| 83605 |
|
60 |
49 |
$123.41 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
77 |
47 |
$95.23 |
| 86140 |
|
82 |
79 |
$93.18 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
12 |
12 |
$86.09 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
117 |
93 |
$74.36 |
| J7050 |
Infusion, normal saline solution, 250 cc |
706 |
230 |
$61.66 |
| 82570 |
|
14 |
14 |
$54.10 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
322 |
233 |
$52.53 |
| 85730 |
|
25 |
24 |
$28.14 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
26 |
25 |
$24.60 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
70 |
64 |
$22.59 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$21.13 |
| J2704 |
Injection, propofol, 10 mg |
15 |
12 |
$16.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
120 |
108 |
$15.52 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
13 |
13 |
$13.75 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
32 |
31 |
$13.42 |
| 84703 |
|
29 |
26 |
$7.66 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
60 |
52 |
$5.90 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
17 |
12 |
$2.45 |
| 84702 |
|
12 |
12 |
$0.00 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
104 |
87 |
$0.00 |
| 87210 |
|
12 |
12 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
39 |
39 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
20 |
14 |
$0.00 |
| 87807 |
|
12 |
12 |
$0.00 |